Clinical trials

  • DUPILUMAB for Chronic pruritus of unknown origin (CPUO)
  • NIVOLUMAB for Malignant melanoma (in-transit metastases)
  • PERINDOPRIL TERT-BUTYLAMINE for Heart failure
  • N/A for Heart failure with reduced ejection fraction (HFrEF)
  • OZANIMOD for Ulcerative colitis
  • TREMELIMUMAB for Resectable hepatocellular carcinoma
  • DNL593 for Frontotemporal dementia | Frontotemporal dementia (GRN mutation)
  • Pyruvic acid for Diabetic kidney disease|Type 1 diabetes mellitus
  • Belantamab mafodotin for Primary immune thrombocytopenia
  • HUMAN (SCFV)2-FAB FUSION PROTEIN AGAINST CD40L for Thyroid eye disease | Graves' disease
  • MOMELOTINIB DIHYDROCHLORIDE MONOHYDRATE for VEXAS syndrome | Myelodysplastic syndrome
  • ABROCITINIB for Atopic dermatitis | Moderate-to-severe atopic dermatitis